Novel insights into the molecular pathogenesis of cyp4v2-associated bietti’s retinal dystrophy

Molecular Genetics and Genomic Medicine

Volumn 3, Issue 1, 2015, Pages 14-29.

  Astuti, Galuh D N ^a,b,c   Sun, Vincent ^d   Bauwens, Miriam ^e   Zobor, Ditta ^f   Leroy, Bart P ^e   Omar, Amer ^d,g   Jurklies, Bernhard ^h   Lopez, Irma ^d   Ren, Huanan ^d   Yazar, Volkan ^a   Hamel, Christian ⁱ   Kellner, Ulrich ^j   Wissinger, Bernd ^f   Kohl, Susanne ^f   Baere, Elfride De ^e   Collin, Rob W J ^a,b   Koenekoop, Robert K ^d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c DIPONEGORO UNIVERSITY   (Indonesia)

^d MONTREAL CHILDREN S HOSPITAL   (Canada)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^g MOORFIELDS EYE HOSPITAL   (United Kingdom)

^h UNIVERSITY OF DUISBURG ESSEN   (Germany)

ⁱ HÔPITAL SAINT ELOI   (France)

^j MVZ ADTC Siegburg GmbH   (Germany)

more..

Author keywords

Bietti; Crystalline dystrophy; CYP4V2; Retinal dystrophy

Indexed keywords

EID: 84962602113     PISSN: None     EISSN: 23249269     Source Type: Journal    
DOI: 10.1002/mgg3.109     Document Type: Article

References (49)

1. Bietti, G. 1937. Ueber familiaeres vorkommen von “retinitis punctata albescens” (verbunden mit “dystrophia marginalis cristallinea corneae”), glitzern des glaskoerpers und anderen degenerativen augenveraenderungen. Klin. Monbl. Augenheilkd. 99:21.
2. Bolton-Maggs, P., B. Wan-Yin, A. McGraw, J. Slack, and P. Kernoff. 1988. Inheritance and bleeding in factor XI deficiency. Br. J. Haematol. 69:521–528.
3. Chung, D. W., K. Fujikawa, B. A. McMullen, and E. W. Davie. 1986. Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats. Biochemistry 25:2410–2417.
4. Chung, J. K., J. H. Shin, B. R. Jeon, C. S. Ki, and T. K. Park. 2013. Optical coherence tomographic findings of crystal deposits in the lens and cornea in Bietti crystalline corneoretinopathy associated with mutation in the CYP4V2 gene. Jpn. J. Ophthalmol. 57:447–450.
5. Collin, R. W., L. I. van den Born, B. J. Klevering, M. de Castro-Miráo, K. W. Littink, K. Arimadyo, et al. 2011. High-resolution homozygosity mapping is a powerful tool to detect novel mutations causative of autosomal recessive RP in the Dutch population. Invest. Ophthalmol. 52:2227–2239.
6. Desmet, F. O., D. Hamroun, M. Lalande, G. Collod-Báeroud, M. Claustres, and C. Báeroud. 2009. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 37:e67.
7. Eisenberger, T., C. Neuhaus, A. O. Khan, C. Decker, M. N. Preising, C. Friedburg, et al. 2013. Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: the example of retinal dystrophies. PLoS One 8:e78496.
8. Fujikawa, K., D. W. Chung, L. E. Hendrickson, and E. W. Davie. 1986. Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein. Biochemistry 25:2417–2424.
9. Haddad, N. M., N. Waked, R. Bejjani, Z. Khoueir, E. Chouery, S. Corbani, et al. 2012. Clinical and molecular findings in three Lebanese families with Bietti crystalline dystrophy: report on a novel mutation. Mol. Vis. 18:1182–1188.
10. Halford, S., G. Liew, D. S. Mackay, P. I. Sergouniotis, R. Holt, S. Broadgate, et al. 2014. Detailed phenotypic and genotypic characterization of Bietti crystalline dystrophy. Ophthalmology 121:1174–1184.
11. Hu, D. N. 1987. Prevalence and mode of inheritance of major genetic eye diseases in China. J. Med. Genet. 24:584–588.
12. Jin, Z. B., S. Ito, Y. Saito, Y. Inoue, Y. Yanagi, and N. Nao-i. 2006. Clinical and molecular findings in three Japanese patients with crystalline retinopathy. Jpn. J. Ophthalmol. 50:426–431.
13. Kojima, H., A. Otani, K. Ogino, S. Nakagawa, Y. Makiyama, M. Kurimoto, et al. 2012. Outer retinal circular structures in patients with Bietti crystalline retinopathy. Br. J. Ophthalmol. 96:390–393.
14. Kravtsov, D., W. Wu, C. M. Meijers, M. F. Sun, M. A. Blinder, T. P. Dang, et al. 2004. Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. Blood. 104:128–134.
15. Lai, T. Y., T. K. Ng, P. O. Tam, G. H. Yam, J. W. Ngai, W. M. Chan, et al. 2007. Genotype phenotype analysis of Bietti’s crystalline dystrophy in patients with CYP4V2 mutations. Invest. Ophthalmol. Vis. Sci. 48:5212–5220.
16. Lai, T. Y., K. O. Chu, K. P. Chan, T. K. Ng, G. H. Yam, D. S. Lam, et al. 2010. Alterations in serum fatty acid concentrations and desaturase activities in Bietti crystalline dystrophy unaffected by CYP4V2 genotypes. Invest. Ophthalmol. Vis. Sci. 51:1092–1097.
17. Lee, J., X. Jiao, J. F. Hejtmancik, M. Kaiser-Kupfer, W. A. Gahl, T. C. Markello, et al. 2001. The metabolism of fatty acids in human Bietti crystalline dystrophy. Invest. Ophthalmol. Vis. Sci. 42:1707–1714.
18. Lee, K. Y., A. H. Koh, T. Aung, V. H. Yong, K. Yeung, C. L. Ang, et al. 2005. Characterization of Bietti crystalline dystrophy patients with CYP4V2 mutations. Invest. Ophthalmol. Vis. Sci. 46:3812–3816.
19. Li, A., X. Jiao, F. L. Munier, D. F. Schorderet, W. Yao, F. Iwata, et al. 2004. Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am. J. Hum. Genet. 74:817–826.
20. Lin, J., K. M. Nishiguchi, M. Nakamura, T. P. Dryja, E. L. Berson, and Y. Miyake. 2005. Recessive mutations in the CYP4V2 gene in East Asian and Middle Eastern patients with Bietti crystalline corneoretinal dystrophy. J. Med. Genet. 42:e38.
21. Lombardi, A. M., M. T. Sartori, L. Cabrio, M. Fadin, E. Zanon, and A. Girolami. 2003. Severe prekallikrein (Fletcher factor) deficiency due to a compound heterozygosis (383Trp stop codon and cys529Tyr). Thromb. Haemost. 90:1040– 1045.
22. Mamatha, G., V. Umashankar, N. Kasinathan, T. Krishnan, R. Sathyabaarathi, T. Karthiyayini, et al. 2011. Molecular screening of the CYP4V2 gene in Bietti crystalline dystrophy that is associated with choroidal neovascularization. Mol. Vis. 17:1970–1977.
23. Mansour, A. M., S. H. Uwaydat, and C. C. Chan. 2007. Long-term follow-up in Bietti crystalline dystrophy. Eur. J. Ophthalmol. 17:680–682.
24. Manzouri, B., P. I. Sergouniotis, A. G. Robson, A. R. Webster, and A. Moore. 2012. Bietti crystalline retinopathy: report of retinal crystal deposition in male adolescent siblings. Arch. Ophthalmol. 130:1470–1473.
25. Marmor, M. F., A. B. Fulton, G. E. Holder, Y. Miyake, M. Brigell, and M. Bach. 2009. Standard for clinical electroretinography. Doc. Ophthalmol. 118:69–77.
26. Mataftsi, A., L. Zografos, E. Milláa, M. Secráetan, and F. L. Munier. 2004. Bietti’s crystalline corneoretinal dystrophy: a cross-sectional study. Retina 24:416–426.
27. Miller, S. A., D. D. Dykes, and H. F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1215.
28. Naito, K., and K. Fujikawa. 1991. Activation of human blood coagulation factor XI independent of factor XII: factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J. Biol. Chem. 266:7353–7358.
29. Nakano, M., E. J. Kelly, and A. E. Rettie. 2009. Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase. Drug Metab. Dispos. 37:2119–2122.
30. Ng, P. C., and S. Henikoff. 2003. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 31:3812–3814.
31. Parravano, M., M. Sciamanna, P. Giorno, A. Boninfante, and M. Varano. 2012. Bietti crystalline dystrophy: a morpho-functional evaluation. Doc. Ophthalmol. 124: 73–77.
32. Pennesi, M. E., and R. G. Weleber. 2013. High-resolution optical coherence tomography shows new aspects of Bietti crystalline retinopathy. Retina 30:531–532.
33. Ragni, M., D. Sinha, F. Seaman, J. Lewis, J. Spero, and P. Walsh. 1985. Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood 65:719–724.
34. Reese, M. G., F. H. Eeckman, D. Kulp, and D. Haussler. 1997. Improved splice site detection in Genie. J. Comput. Biol. 4:311–323.
35. Rossi, S., F. Testa, A. Li, F. Yaylacioáglu, C. Gesualdo, J. F. Hejtmancik, et al. 2013. Clinical and genetic features in Italian Bietti crystalline dystrophy patients. Br. J. Ophthalmol. 97:174–179.
36. Sainz, I. M., R. A. Pixley, and R. W. Colman. 2007. Fifty years of research on the plasma kallikrein-kinin system: from protein structure and function to cell biology and in-vivo pathophysiology. Thromb. Haemost. 98:77–83.
37. Shan, M., B. Dong, X. Zhao, J. Wang, G. Li, Y. Yang, et al. 2005. Novel mutations in the CYP4V2 gene associated with Bietti crystalline corneoretinal dystrophy. Mol. Vis. 11:738– 743.
38. Song, Y., G. Mo, and G. Yin. 2013. A novel mutation in the CYP4V2 gene in a Chinese patient with Bietti’s crystalline dystrophy. Int. Ophthalmol. 33:269–276.
39. Wada, Y., T. Itabashi, H. Sato, M. Kawamura, A. Tada, and M. Tamai. 2005. Screening for mutations in CYP4V2 gene in Japanese patients with Bietti’s crystalline corneoretinal dystrophy. Am. J. Ophthalmol. 139:894–899.
40. Wilson, D. J., R. G. Weleber, M. L. Klein, R. B. Welch, and W. R. Green. 1989. Bietti’s crystalline dystrophy. A clinicopathologic correlative study. Arch. Ophthalmol. 107:213–221.
41. Wissinger, B., S. Schaich, B. Baumann, M. Bonin, H. Jüagle, C. Friedburg, et al. 2011. Large deletions of the KCNV2 gene are common in patients with cone dystrophy with supernormal rod response. Hum. Mutat. 32:1398–1406.
42. Wynne Jones, D., G. Russell, S. L. Allford, K. Burdon, G. A. Hawkins, D. W. Bowden, et al. 2004. Severe prekallikrein deficiency associated with homozygosity for an Arg94Stop nonsense mutation. Br. J. Haematol. 127:220–223.
43. Xiao, X., G. Mai, S. Li, X. Guo, and Q. Zhang. 2011. Identification of CYP4V2 mutation in 21 families and overview of mutation spectrum in Bietti crystalline corneoretinal dystrophy. Biochem. Biophys. Res. Commun. 409:181–186.
44. Yeo, G., and C. B. Burge. 2004. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 11:377–394.
45. Yin, H., C. Jin, X. Fang, Q. Miao, Y. Zhao, Z. Chen, et al. 2014. Molecular analysis and phenotypic study in 14 Chinese families with Bietti crystalline dystrophy. PLoS One 9:e94960.
46. Yokoi, Y., M. Nakazawa, S. Mizukoshi, K. Sato, T. Usui, and K. Takeuchi. 2010. Crystal deposits on the lens capsules in Bietti crystalline corneoretinal dystrophy associated with a mutation in the CYP4V2 gene. Acta Ophthalmol. 88:607– 609.
47. Yokoi, Y., K. Sato, H. Aoyagi, Y. Takahashi, M. Yamagami, and M. A. Nakazawa. 2011. Novel compound heterozygous mutation in the CYP4V2 gene in a Japanese patient with Bietti’s crystalline corneoretinal dystrophy. Case Rep. Ophthalmol. 2:296–301.
48. Zenteno, J. C., R. Ayala-Ramirez, and F. Graue-Wiechers. 2008. Novel CYP4V2 gene mutation in a Mexican patient with Bietti’s crystalline corneoretinal dystrophy. Curr. Eye Res. 33:313–318.
49. Zweifel, S. A., M. Engelbert, K. Laud, R. Margolis, R. F. Spaide, and K. B. Freund. 2009. Outer retinal tubulation: a novel optical coherence tomography finding. Arch. Ophthalmol. 127:1596–1602.